Abstract

Protecting the whole small intestine from radiation-induced intestinal injury during the radiotherapy of abdominal or pelvic solid tumors remains an unmet clinical need. Amifostine is a promising selective radioprotector for normal tissues. However, its oral application in intestinal radioprotection remains challenging. Herein, we use microalga Spirulina platensis as a microcarrier of Amifostine to construct an oral delivery system. The system shows comprehensive drug accumulation and effective radioprotection in the whole small intestine that is significantly superior to free drug and its enteric capsule, preventing the radiation-induced intestine injury and prolonging the survival without influencing the tumor regression. It also shows benefits on the gut microbiota homeostasis and long-term safety. Based on a readily available natural microcarrier, this work presents a convenient oral delivery system to achieve effective radioprotection for the whole small intestine, providing a competitive strategy with great clinical translation potential.

Protecting the whole small intestine from radiation-induced intestinal injury during the radiotherapy of abdominal or pelvic solid tumors remains an unmet clinical need. Here the authors use a natural microalga to readily construct an oral delivery system to achieve effective radioprotection for the small intestine.

Details

Title
Microalgae-based oral microcarriers for gut microbiota homeostasis and intestinal protection in cancer radiotherapy
Author
Zhang, Dongxiao 1 ; Zhong Danni 1 ; Ouyang, Jiang 2 ; He, Jian 3 ; Qi Yuchen 3 ; Chen, Wei 2 ; Zhang, Xingcai 4   VIAFID ORCID Logo  ; Tao, Wei 2   VIAFID ORCID Logo  ; Zhou, Min 5   VIAFID ORCID Logo 

 Zhejiang University School of Medicine, Department of Respiratory and Critical Care Medicine, The Fourth Affiliated Hospital, Yiwu, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X); Zhejiang University, Institute of Translational Medicine, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X) 
 Harvard Medical School, Center for Nanomedicine and Department of Anesthesiology, Brigham and Women’s Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
 Zhejiang University, Institute of Translational Medicine, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X) 
 Harvard University, School of Engineering and Applied Sciences, Cambridge, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Massachusetts Institute of Technology, School of Engineering, Cambridge, USA (GRID:grid.116068.8) (ISNI:0000 0001 2341 2786) 
 Zhejiang University School of Medicine, Department of Respiratory and Critical Care Medicine, The Fourth Affiliated Hospital, Yiwu, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X); Zhejiang University, Institute of Translational Medicine, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X); Zhejiang University, State Key Laboratory of Modern Optical Instrumentations, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X); Zhejiang University, Cancer Center, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2640592832
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.